[1]
“An Evaluation of the Pharmacokinetics and Virtual Screening of Highly Effective Hybrid Compounds for Alzheimer’s Disease”, J Environ Bioremed Toxicol, vol. 7, no. 2, pp. 63–74, Dec. 2024, doi: 10.54987/jebat.v7i2.1046.